Kerecis Competitors, Revenue, Alternatives and Pricing

Claim your profile


Isafjordur, USA
Total Funding:N/A
Industry:Medical Equip
Lead Investor(s):N/A

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Kerecis's estimated annual revenue is currently $26.4M per year.(?)
  • Kerecis's estimated revenue per employee is $251,000

Employee Data

  • Kerecis has 105 Employees.(?)
  • Kerecis grew their employee count by 17% last year.
  • Kerecis currently has 5 job openings.

Kerecis has developed the unique, patented Kerecis™ Omega3 fish-skin transplantation technology, where intact fish skin is used for tissue regeneration. The Kerecis™ Omega3 transplantation technology is used to reconstruct tissue damage such as burn and diabetic wounds as well as for oral wounds, hernia repair, breast reconstruction and for dura restoration. Other tissue-transplant products are based on tissues of human and porcine origin. The Kerecis™ Omega3 fish skin offers improved economics and clinical performance, as well as reduced disease transfer risk and no cultural constraints on usage. Kerecis’ second technology platform is the patented mOmega3 polyunsaturated fatty acid technology, where fatty acids are extracted from fish skin and incorporated in patented dermatological skin treatment products.

keywords:Biotechnology, Medical Devices